• Home
  • About
  • Services
  • Blog
  • Contact
Optimizing 340B Policies and Procedures for Compliance

Optimizing 340B Policies and Procedures for Compliance

by Realistic Strategies | Apr 1, 2025 | 340B

At Realistic Strategies LLC, we understand that 340B compliance is a top priority for covered entities. Our 340B Audit Series is designed to provide actionable insights, best practices, and expert guidance to help your organization navigate the complexities of HRSA...
340B Rebate Model: Why It Won’t Lower Patient Costs

340B Rebate Model: Why It Won’t Lower Patient Costs

by Realistic Strategies | Mar 25, 2025 | 340B

What Is the 340B Drug Pricing Program? The 340B Drug Pricing Program was established in 1992 to help safety-net healthcare providers stretch resources and expand access to care for underserved populations. Pharmaceutical manufacturers must sell outpatient drugs at...
Optimizing 340B Policies and Procedures for Compliance

Reflecting on 340B Audits: Trends and Takeaways (Part 1)

by Realistic Strategies | Mar 7, 2025 | 340B

Reflecting on 340B Audits: Trends and Key Takeaways (2020-2024) Over the past five years, 340B program audits have continued to play a crucial role in ensuring compliance for participating covered entities. With increasing scrutiny from the Health Resources and...
PBM Barriers for 340B Programs to Reduce Patient Costs

PBM Barriers for 340B Programs to Reduce Patient Costs

by Realistic Strategies | Feb 10, 2025 | 340B

Introduction The 340B Drug Pricing Program was established to enable eligible healthcare providers, known as covered entities, to purchase outpatient medications at discounted rates, thereby supporting vulnerable patient populations. However, the intended benefits of...
Defending 340B: A Call to Action Against Johnson & Johnson’s Rebate Maneuver

Defending 340B: A Call to Action Against Johnson & Johnson’s Rebate Maneuver

by Realistic Strategies | Sep 30, 2024 | 340B

As 340B Consultants and avid program supporters who have witnessed firsthand the profound impact this program has on providing essential healthcare services to vulnerable and underserved populations, we’re deeply concerned about Johnson & Johnson’s...